Jun Deng

Healthier skin starts here - with the first & only employee benefit focused on preventative skin health and wellness. We believe prevention is better than a cure. Thats why at JOYA, were dedicated to saving lives and changing the way you look & feel in your own skin by offering access to education, an accredited provider network - at an affordable cost. Skin cancer is the #1 form of cancer in the US with 1 in 5 people being diagnosed in their lifetime. Yet skin cancer is 99% treatable if detected early. With a limited amount of dermatologists available in the US with an average wait time of 4-6 months to schedule your visit - theres a gap in the system. JOYA is here to fill this gap, by growing a quality, accredited provider network skilled to detect early signs of skin cancer. Our members unlock priority access with our skin health experts and receive over $1000 in credits & benefits to use annually towards preventative skin health services & products, including complimentary skin cancer screenings. Your skin is bodys largest organ - dont let your health benefits ignore this. Learn if your employer offers JOYA today!

C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer. Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.

Nymbl is the first scalable fall prevention solution. We are the only digital, in-home balance training program that provides real solutions to leading Medicare and Medicaid plans: • 3x higher engagement at 1/50th of the cost • Increased star ratings • Member satisfaction • Improved population health • No IT integration required • HIPAA compliant • Quick deployment If youre ready to implement an effective fall prevention solution, reach out to us now: contact@nymblscience.com

We are an advanced biomaterials and biofabrication company.

Lark’s mission is to create compassionate technology that empowers people everywhere to live healthier lives. As a leading expert in AI digital health tech, Larks platform leverages conversational AI health coaching and connected devices to create a modern, personalized consumer experience for the prevention and management of chronic conditions. Having been in the healthcare AI space for over a decade, Lark is the largest health planprovider for clinically proven obesity and pre-diabetes prevention programs. To date, Lark is providing over 2 million people with real-time, 24/7 personalized care coaching delivered through an easy-to-use, text message-like interface. Larks platform easily scales to right-size itself for an organization’s total population needs, while seamlessly integrating with health plans and employers existing healthcare and benefits infrastructure. Lark currently provides programs across the entire care continuum, including Weight Management Solutions, Prevention, Heart Health, Diabetes Prevention, Diabetes Management, and Hypertension Management. Larks Diabetes Prevention Program (DPP), which has received Full Recognition from the Centers for Disease Control and Prevention (CDC). The company has received numerous accolades, including having been named as one of CB Insights Digital Health 150, a finalist for the UCSF Digital Health Awards, and one of Fierce Healthcares Fierce 15.

Noctrix Health is pioneering the next-generation of therapeutic wearables that empower patients to take control of their chronic medical conditions. We aim to provide a powerful, efficacious and cost-effective alternative to pharmaceutical therapies.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home. HealthTech is now an exploding healthcare market that leverages information technologies to decrease healthcare cost. Historically, venture funding has focused on “Efficacy” (therapeutics drugs and medical devices) and paid little attention to improving “Efficiencies” of healthcare delivery. Today, new paradigm shifting companies like Google, Microsoft, Intel, Apple, Amazon and others are turning their attention to HealthTech. HealthTech supports patient-centric healthcare and is distinct from Healthcare IT, enterprise backbone legacy information systems that are well served by existing major players. Our goal is to invest in capital efficient companies that use new business models to improve the efficiency of healthcare delivery.

Osmosis.org is a leading health education platform with an audience of millions of current and future healthcare professionals and their patients and family members (https://www.osmosis.org/world). Our vision is to create a more caring world by developing the most caring people. To learn more please visit www.osmosis.org/about and to see what career opportunities are available please visit www.osmosis.org/careers.

Zūm has reimagined student transportation— managing every vehicle, driver, passenger, parent, and ride on a single platform. We’re growing fast and looking for super-smart folks motivated to fix the nations largest mass transportation system and make a real difference for students, schools, drivers, parents and caregivers. If fixing an antiquated system hidden in plain sight excites you, drop us a note at apply@ridezum.com today.

Foothill Ventures is a technology-focused venture fund based in Los Altos, California. Our team of passionate investors brings deep experience as founders and operators. We focus on frontier tech, making early-stage investments in infrastructure and AI applications.

Loop Genomics is the only hardware-free synthetic long read sequencing approach that transforms any short read sequencer into a single molecule long read sequencer. The company has developed proprietary sample prep and software that tag DNA/RNA molecules with DNA barcodes and copies and pastes those barcodes intra-molecularly throughout long molecules. Once barcodes are distributed intra-molecularly, libraries are converted into a standard short read library and sequenced on any short read sequencer. After sequencing, reads with the same barcodes are grouped together and assembled back into the longer molecules that were tagged by those barcode using Loops software. Loop sequencing is used to assemble genomes, transcriptomes or targeted amplicons from long reads, providing highly accurate, single molecule long read data for any application and leveraging your existing short read infrastructure.

BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers. Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers. Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.

Opentrons Labworks, Inc., is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. Opentrons Labworks is the parent company to business units Opentrons Robotics and Neochromosome. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling lab robots. Through Neochromosome, biopharma and biotech at large can benefit from our world-class genome-scale cell engineering solutions. Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science labs. Our open-source ecosystem offers the scientific community the tools they need to automate experiments, share protocols and reproduce each others results. Opentrons robots can be found in thousands of academic, biopharma, synthetic biology and clinical research labs in more than 40 countries.

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be the first deeptech-focused venture capital firm founded by Tsinghua alumni in Silicon Valley. Over 14 years of operation, TSVC has invested in over 200 startups and has been ranked in the top decile of early-stage funds in the US. With top domain expertise and extensive startup experience, our partners bring distinctive value-add to our entrepreneurs along with capital investment. At TSVC, we are your peers in entrepreneurship. We’ve been exactly where you are. With engineering know-how and business experience in the tech industry, we invest in early-stage startups and provide the guidance, foundation, and infrastructure needed to raise great companies from the ground up. We’ll be your pillars every step of the way to connect, collaborate and help cultivate your visions into category-defining companies that make our planet a better place to live, love, and thrive.

Ataraxia is an early-stage fund manager focused on helping people live longer and live better. Scientific breakthroughs are making it possible for us to extend our active lifespan and be our best selves in body, mind, and spirit. This new democratization of health is propelled by purpose and centered on maximized well being. Through these intertwined strands, health and happiness cyclically drive one another. Ataraxia currently manages two funds: Joyance Partners, investing in delightful moments, and SH2, investing in the science of Health and Happiness. Joyance Partners: https://www.joyancepartners.com/ Social Starts Health and Happiness: http://sh2.vc

Healthier skin starts here - with the first & only employee benefit focused on preventative skin health and wellness. We believe prevention is better than a cure. Thats why at JOYA, were dedicated to saving lives and changing the way you look & feel in your own skin by offering access to education, an accredited provider network - at an affordable cost. Skin cancer is the #1 form of cancer in the US with 1 in 5 people being diagnosed in their lifetime. Yet skin cancer is 99% treatable if detected early. With a limited amount of dermatologists available in the US with an average wait time of 4-6 months to schedule your visit - theres a gap in the system. JOYA is here to fill this gap, by growing a quality, accredited provider network skilled to detect early signs of skin cancer. Our members unlock priority access with our skin health experts and receive over $1000 in credits & benefits to use annually towards preventative skin health services & products, including complimentary skin cancer screenings. Your skin is bodys largest organ - dont let your health benefits ignore this. Learn if your employer offers JOYA today!

C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer. Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.

Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world’s most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVBs parent company, First Citizens Bancshares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn more at svb.com. Please contact client service at https://www.svb.com/client-service/help-desk/ for all account questions. To ensure your information is secure, please do not include any personal account information in posts or messages. Please visit https://jobs.firstcitizens.com/ if you are interested in a career at SVB. Comments are moderated and will be removed if they are off-topic or abusive. Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as well as the other divisions, subsidiaries, and affiliates of First-Citizens Bank & Trust Company (together, SVB), are U.S. financial institutions and provide products and services to non-U.S. clients on a cross-border basis from the United States of America. SVB is not licensed or regulated as a bank or any other type of financial institution outside of the United States of America. Please review our International Disclosures for more information: https://www.svb.com/international-disclosures/

The Endless Frontier Labs (EFL) is a nine-month, goal-oriented mentorship program at NYU Stern School of Business designed for early-stage science and technology startups worldwide (no NYU affiliation required). EFL helps transform breakthrough scientific and technological innovations into high-impact businesses. Participating startups receive mentorship from an elite network of successful entrepreneurs, business leaders, investors, and scientists, drawn from New York and beyond. EFL is a unique, “founders first” program and does not charge fees or take equity in startups, and participating startups are drawn from all over the world.